Crossmark

Inhibition of PI3K/Akt/mTOR signaling pathway alleviates ovarian cancer chemoresistance through reversing epithelial-mesenchymal transition and decreasing cancer stem cell marker expression

Crossref DOI link: https://doi.org/10.1186/s12885-019-5824-9

Published Online: 2019-06-24

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Deng, Junli

Bai, Xupeng

Feng, Xiaojie

Ni, Jie

Beretov, Julia

Graham, Peter

Li, Yong
Funding

Funding for this research was provided by:

China Sponsorship Council (N/A, N/A)
License Information

Text and Data Mining valid from 2019-06-24

Version of Record valid from 2019-06-24
More Information

Article History

Received: 22 March 2019

Accepted: 12 June 2019

First Online: 24 June 2019

Ethics approval and consent to participate

: Not applicable.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below